Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H9O2.H4N |
Molecular Weight | 119.1622 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[NH4+].CCCCC([O-])=O
InChI
InChIKey=RXQNHIDQIJXKTK-UHFFFAOYSA-N
InChI=1S/C5H10O2.H3N/c1-2-3-4-5(6)7;/h2-4H2,1H3,(H,6,7);1H3
Valeric acid is a colorless, oily liquid with an unpleasant odor. It is highly corrosive and must be handled with care. Valeric acid is mainly used as a chemical intermediate to manufacture flavors and perfumes, synthetic lubricants, agricultural chemicals, and pharmaceuticals. It is also used as a flavoring aid in foods. Valeric acid is considered safe as a food additive by the World Health Organization.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Influence of yeast culture on ruminal microbial metabolism in continuous culture. | 2002 Aug |
|
Sensitization of trigeminal caudalis neuronal responses to intraoral acid and salt stimuli and desensitization by nicotine. | 2002 Aug |
|
Controlling deuterium isotope effects in comparative proteomics. | 2002 Aug 1 |
|
Effects of culture conditions on the production of polyhydroxyalkanoates by Azotobacter chroococcum H23 in media containing a high concentration of alpechín (wastewater from olive oil mills) as primary carbon source. | 2002 Aug 7 |
|
A novel synthesis of (+)-biotin from L-cysteine. | 2002 Aug 9 |
|
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. | 2002 Dec 21-28 |
|
Metabolic characteristics of the faecal microflora in humans from three age groups. | 2002 Jul |
|
Development of a headspace solid-phase microextraction-gas chromatography-mass spectrometry method for the identification of odour-causing volatile compounds in packaging materials. | 2002 Jul 19 |
|
Characterization of copolymer hydroxybutyrate/hydroxyvalerate from saponified vernonia, soybean, and "spent" frying oils. | 2002 Jul-Aug |
|
Cyproterone acetate could counteract the benefits of estradiol valerate in oophorectomized cholesterol-fed rabbits. | 2002 Jul-Aug |
|
1H and (13)C NMR spectroscopic analysis of human saliva. | 2002 Jun |
|
A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli. | 2002 Jun |
|
Acylated triterpenoid saponins from the stem bark of Foetidia africana. | 2002 Nov |
|
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. | 2002 Nov 20 |
|
Polymers for biodegradable medical devices XI. Microencapsulation studies: characterization of hydrocortisone-loaded poly-hydroxybutyrate-hydroxyvalerate microspheres. | 2002 Nov-Dec |
|
Enhancement of NGF- and cholera toxin-induced neurite outgrowth by butyrate in PC12 cells. | 2002 Oct 4 |
|
Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. | 2003 |
|
Liquefaction and methanization of solid and liquid coffee wastes by two phase anaerobic digestion process. | 2003 |
|
Hydrogen production from wastewater by acidogenic granular sludge. | 2003 |
|
Psychophysical evaluation of responses to pleasant and mal-odour stimulation in human subjects; adaptation, dose response and gender differences. | 2003 Apr |
|
Effects of hydrochloric, valeric, and other volatile fatty acids on pathogenesis of ulcers in the nonglandular portion of the stomach of horses. | 2003 Apr |
|
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. | 2003 Apr |
|
Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. | 2003 Apr 18 |
|
Activation of neurons in trigeminal caudalis by noxious oral acidic or salt stimuli is not reduced by amiloride. | 2003 Apr 18 |
|
Parameter identification of thermophilic anaerobic degradation of valerate. | 2003 Apr-Jun |
|
Synthesis and cytotoxicity of new platinum(IV) complexes of mixed carboxylates. | 2003 Aug 1 |
|
Conformationally constrained analogues of bleomycin A5. | 2003 Aug 27 |
|
Effect of method of application of a fibrolytic enzyme product on digestive processes and milk production in Holstein-Friesian cows. | 2003 Feb |
|
Enhanced biosynthesis of polyhydroxyalkanoates in a mutant strain of Rhizobium meliloti. | 2003 Jan |
|
Eubacterium pyruvativorans sp. nov., a novel non-saccharolytic anaerobe from the rumen that ferments pyruvate and amino acids, forms caproate and utilizes acetate and propionate. | 2003 Jul |
|
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. | 2003 Jul |
|
Dynamics of the anaerobic process: effects of volatile fatty acids. | 2003 Jun 30 |
|
Improvement of (+)-catechin inhibitory activity on human PMN respiratory burst by (+)-3-O-propionyl and (-)-3-O-valeryl substitution. | 2003 Mar |
|
Lack of quinine-evoked activity in rat trigeminal subnucleus caudalis. | 2003 Mar |
|
Optimizing the level of wet corn gluten feed in the diet of lactating dairy cows. | 2003 Mar |
|
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. | 2003 Mar 28 |
|
Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction. | 2003 Mar-Apr |
|
Production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with high molar fractions of 3-hydroxyvalerate by a threonine-overproducing mutant of Alcaligenes sp. SH-69. | 2003 May |
|
[Anti-arrhythmia activity of estradiol valerate and estradiol nitrate]. | 2003 May-Jun |
|
Heterogeneous acylation of flax fibers. Reaction kinetics and surface properties. | 2003 May-Jun |
|
Ruminal fermentation and bacterial protein synthesis of whole cottonseed coated with combinations of gelatinized corn starch and urea. | 2003 Nov |
|
Pelleted beet pulp substituted for high-moisture corn: 3. Effects on ruminal fermentation, pH, and microbial protein efficiency in lactating dairy cows. | 2003 Nov |
|
Mecamylamine reduces nicotine cross-desensitization of trigeminal caudalis neuronal responses to oral chemical irritation. | 2003 Nov 21 |
|
Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha. | 2003 Oct 17 |
|
Kinetics of thermophilic, anaerobic oxidation of straight and branched chain butyrate and valerate. | 2003 Oct 20 |
|
Synthesis, X-ray crystal structure, UV/visible linear and nonlinear (optical limiting) spectral properties of symmetrical and unsymmetrical porphyrazines with annulated 1,2,5-thiadiazole and 1,4-diamyloxybenzene moieties. | 2003 Sep 5 |
|
The degradability of biodegradable plastics in aerobic and anaerobic waste landfill model reactors. | 2004 Jan |
|
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. | 2004 Jan 27 |
|
Sequential feeding of glucose and valerate in a fed-batch culture of Ralstonia eutropha for production of poly(hydroxybutyrate-co-hydroxyvalerate) with high 3-hydroxyvalerate fraction. | 2004 Jan-Feb |
|
Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. | 2004 Mar |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26663903
1.5 mM valeric acid is an effective chemical reagent to increase mAb production in rCHO cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m559
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
255-923-3
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
0U3170A41K
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
0U3170A41K
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
162525
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
42739-38-8
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
C83534
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
DTXSID00885874
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | |||
|
1441545
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL2106510
Created by
admin on Fri Dec 15 15:32:45 GMT 2023 , Edited by admin on Fri Dec 15 15:32:45 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD